DAXOR CORP

Daxor Corp.

Medical Instruments & Supplies Healthcare Oak Ridge, TN, United States DXR (NCM)

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation is a subsidiary of Estate Of Joseph Feldschuh.

Stock Performance (90 Days)

Data through Dec 26, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Other Medical Instruments & Supplies Companies

View All →

Frequently Asked Questions

Has DAXOR CORP had layoffs?
No layoff events have been recorded for DAXOR CORP in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
What industry is DAXOR CORP in?
DAXOR CORP operates in the Medical Instruments & Supplies industry, within the Healthcare sector.
Is DAXOR CORP a publicly traded company?
Yes, DAXOR CORP is publicly traded under the ticker symbol DXR on the NCM. The company has a market capitalization of approximately $0.07 billion.
Where is DAXOR CORP headquartered?
DAXOR CORP is headquartered in Oak Ridge, TN, United States at 109 Meco Lane, Oak Ridge, TN 37830, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.